nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—DRD1—attention deficit hyperactivity disorder	0.357	0.444	CbGaD
Flupentixol—DRD2—attention deficit hyperactivity disorder	0.252	0.313	CbGaD
Flupentixol—HTR2A—attention deficit hyperactivity disorder	0.194	0.242	CbGaD
Flupentixol—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.0064	0.143	CbGeAlD
Flupentixol—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.0034	0.0759	CbGeAlD
Flupentixol—DDC—forebrain—attention deficit hyperactivity disorder	0.00277	0.0617	CbGeAlD
Flupentixol—DRD1—forebrain—attention deficit hyperactivity disorder	0.00203	0.0454	CbGeAlD
Flupentixol—DDC—midbrain—attention deficit hyperactivity disorder	0.00183	0.0408	CbGeAlD
Flupentixol—DDC—nervous system—attention deficit hyperactivity disorder	0.0015	0.0335	CbGeAlD
Flupentixol—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00149	0.0333	CbGeAlD
Flupentixol—DDC—central nervous system—attention deficit hyperactivity disorder	0.00145	0.0323	CbGeAlD
Flupentixol—DRD1—midbrain—attention deficit hyperactivity disorder	0.00134	0.03	CbGeAlD
Flupentixol—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00126	0.0281	CbGeAlD
Flupentixol—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00123	0.0273	CbGeAlD
Flupentixol—DRD2—forebrain—attention deficit hyperactivity disorder	0.0012	0.0268	CbGeAlD
Flupentixol—DDC—brain—attention deficit hyperactivity disorder	0.00115	0.0256	CbGeAlD
Flupentixol—DRD1—nervous system—attention deficit hyperactivity disorder	0.0011	0.0246	CbGeAlD
Flupentixol—DRD1—central nervous system—attention deficit hyperactivity disorder	0.00106	0.0237	CbGeAlD
Flupentixol—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00104	0.0231	CbGeAlD
Flupentixol—DRD1—brain—attention deficit hyperactivity disorder	0.000844	0.0188	CbGeAlD
Flupentixol—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00081	0.0181	CbGeAlD
Flupentixol—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000798	0.101	CrCbGaD
Flupentixol—DRD2—midbrain—attention deficit hyperactivity disorder	0.000793	0.0177	CbGeAlD
Flupentixol—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000793	0.0177	CbGeAlD
Flupentixol—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00078	0.0174	CbGeAlD
Flupentixol—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00067	0.0149	CbGeAlD
Flupentixol—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000666	0.0148	CbGeAlD
Flupentixol—DRD2—nervous system—attention deficit hyperactivity disorder	0.000652	0.0145	CbGeAlD
Flupentixol—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000641	0.0143	CbGeAlD
Flupentixol—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000628	0.014	CbGeAlD
Flupentixol—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000626	0.014	CbGeAlD
Flupentixol—CHRM1—brain—attention deficit hyperactivity disorder	0.000619	0.0138	CbGeAlD
Flupentixol—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000614	0.0137	CbGeAlD
Flupentixol—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000546	0.0688	CrCbGaD
Flupentixol—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000523	0.0117	CbGeAlD
Flupentixol—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000519	0.0116	CbGeAlD
Flupentixol—ADRA1A—brain—attention deficit hyperactivity disorder	0.000509	0.0113	CbGeAlD
Flupentixol—DRD2—brain—attention deficit hyperactivity disorder	0.000499	0.0111	CbGeAlD
Flupentixol—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000461	0.0581	CrCbGaD
Flupentixol—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000439	0.00979	CbGeAlD
Flupentixol—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000435	0.0548	CrCbGaD
Flupentixol—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00043	0.0096	CbGeAlD
Flupentixol—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000414	0.00924	CbGeAlD
Flupentixol—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000405	0.00903	CbGeAlD
Flupentixol—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000385	0.0485	CrCbGaD
Flupentixol—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000346	0.0435	CrCbGaD
Flupentixol—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000343	0.00765	CbGeAlD
Flupentixol—HTR2A—brain—attention deficit hyperactivity disorder	0.000329	0.00733	CbGeAlD
Flupentixol—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000321	0.0405	CrCbGaD
Flupentixol—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000298	0.0375	CrCbGaD
Flupentixol—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000282	0.00629	CbGeAlD
Flupentixol—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000277	0.0349	CrCbGaD
Flupentixol—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000271	0.00605	CbGeAlD
Flupentixol—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000265	0.00592	CbGeAlD
Flupentixol—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000262	0.033	CrCbGaD
Flupentixol—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000257	0.0324	CrCbGaD
Flupentixol—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000244	0.0307	CrCbGaD
Flupentixol—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000239	0.0301	CrCbGaD
Flupentixol—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000236	0.0297	CrCbGaD
Flupentixol—ABCB1—brain—attention deficit hyperactivity disorder	0.000216	0.00481	CbGeAlD
Flupentixol—Thiothixene—DRD2—attention deficit hyperactivity disorder	0.00021	0.0265	CrCbGaD
Flupentixol—Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.00021	0.0264	CrCbGaD
Flupentixol—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.000204	0.0256	CrCbGaD
Flupentixol—Quetiapine—DRD3—attention deficit hyperactivity disorder	0.000203	0.0256	CrCbGaD
Flupentixol—Quetiapine—DRD1—attention deficit hyperactivity disorder	0.0002	0.0251	CrCbGaD
Flupentixol—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000189	0.0238	CrCbGaD
Flupentixol—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	0.000188	0.0237	CrCbGaD
Flupentixol—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	0.000186	0.0234	CrCbGaD
Flupentixol—Fluphenazine—DRD2—attention deficit hyperactivity disorder	0.000182	0.0229	CrCbGaD
Flupentixol—Thiothixene—HTR2A—attention deficit hyperactivity disorder	0.000162	0.0204	CrCbGaD
Flupentixol—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	0.000145	0.0183	CrCbGaD
Flupentixol—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.000144	0.0181	CrCbGaD
Flupentixol—Quetiapine—DRD2—attention deficit hyperactivity disorder	0.000141	0.0177	CrCbGaD
Flupentixol—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	0.00014	0.0177	CrCbGaD
Flupentixol—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	0.000112	0.0141	CrCbGaD
Flupentixol—Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.000111	0.014	CrCbGaD
Flupentixol—Quetiapine—HTR2A—attention deficit hyperactivity disorder	0.000109	0.0137	CrCbGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.17e-05	0.000566	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.13e-05	0.000563	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.1e-05	0.000561	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.04e-05	0.000557	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.03e-05	0.000556	CbGpPWpGaD
Flupentixol—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8e-05	0.000554	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8e-05	0.000554	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8e-05	0.000554	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.93e-05	0.00055	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.91e-05	0.000548	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.91e-05	0.000548	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	7.9e-05	0.000548	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	7.88e-05	0.000546	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	7.87e-05	0.000545	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	7.86e-05	0.000545	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.8e-05	0.000541	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.78e-05	0.000539	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.76e-05	0.000538	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.75e-05	0.000537	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	7.74e-05	0.000536	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.74e-05	0.000536	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	7.65e-05	0.00053	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.64e-05	0.00053	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.62e-05	0.000528	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	7.53e-05	0.000522	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	7.52e-05	0.000521	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.45e-05	0.000516	CbGpPWpGaD
Flupentixol—DDC—Metabolism—TPH2—attention deficit hyperactivity disorder	7.39e-05	0.000512	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.39e-05	0.000512	CbGpPWpGaD
Flupentixol—DDC—Metabolism—DPYD—attention deficit hyperactivity disorder	7.27e-05	0.000504	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.27e-05	0.000504	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.23e-05	0.000501	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.12e-05	0.000493	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.97e-05	0.000483	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.91e-05	0.000479	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.85e-05	0.000475	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	6.84e-05	0.000474	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.8e-05	0.000471	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.76e-05	0.000469	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.76e-05	0.000468	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	6.73e-05	0.000467	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.66e-05	0.000461	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.58e-05	0.000456	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.47e-05	0.000449	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.45e-05	0.000447	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.44e-05	0.000446	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.42e-05	0.000445	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.34e-05	0.000439	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000439	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.32e-05	0.000438	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.31e-05	0.000437	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.29e-05	0.000436	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.22e-05	0.000431	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.21e-05	0.00043	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.19e-05	0.000429	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.12e-05	0.000424	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.12e-05	0.000424	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.09e-05	0.000422	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.04e-05	0.000419	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.04e-05	0.000419	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.02e-05	0.000417	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.99e-05	0.000415	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.99e-05	0.000415	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.97e-05	0.000414	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.94e-05	0.000412	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.92e-05	0.00041	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.91e-05	0.00041	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.91e-05	0.00041	CbGpPWpGaD
Flupentixol—DDC—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.91e-05	0.000409	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	5.9e-05	0.000409	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.89e-05	0.000408	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.88e-05	0.000407	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.85e-05	0.000406	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.85e-05	0.000405	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.82e-05	0.000403	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.82e-05	0.000403	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.76e-05	0.000399	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.76e-05	0.000399	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.73e-05	0.000397	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.64e-05	0.000391	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	5.63e-05	0.00039	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.62e-05	0.00039	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.54e-05	0.000384	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.51e-05	0.000382	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.44e-05	0.000377	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.42e-05	0.000376	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.37e-05	0.000372	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.26e-05	0.000365	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.22e-05	0.000362	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.18e-05	0.000359	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.18e-05	0.000359	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.18e-05	0.000359	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.17e-05	0.000358	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.15e-05	0.000357	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.07e-05	0.000351	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.000351	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.99e-05	0.000345	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.71e-05	0.000326	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.7e-05	0.000325	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.67e-05	0.000324	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.66e-05	0.000323	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.58e-05	0.000317	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.58e-05	0.000317	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.52e-05	0.000313	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.49e-05	0.000311	CbGpPWpGaD
Flupentixol—DDC—Metabolism—COMT—attention deficit hyperactivity disorder	4.48e-05	0.00031	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.47e-05	0.00031	CbGpPWpGaD
Flupentixol—DDC—Metabolism—MAOA—attention deficit hyperactivity disorder	4.45e-05	0.000308	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.4e-05	0.000305	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.37e-05	0.000303	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.3e-05	0.000298	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.23e-05	0.000293	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.21e-05	0.000292	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.16e-05	0.000288	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.11e-05	0.000285	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.11e-05	0.000284	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.06e-05	0.000281	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.04e-05	0.00028	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.02e-05	0.000279	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.99e-05	0.000277	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.97e-05	0.000275	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.96e-05	0.000274	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.000273	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000271	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.91e-05	0.000271	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.91e-05	0.000271	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.86e-05	0.000267	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.84e-05	0.000266	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.82e-05	0.000265	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.82e-05	0.000265	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.82e-05	0.000265	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.8e-05	0.000263	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.76e-05	0.000261	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.63e-05	0.000252	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.57e-05	0.000248	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.55e-05	0.000246	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.55e-05	0.000246	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.53e-05	0.000245	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.52e-05	0.000244	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000242	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.49e-05	0.000242	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.47e-05	0.000241	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.47e-05	0.00024	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.46e-05	0.00024	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.46e-05	0.00024	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.46e-05	0.000239	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.45e-05	0.000239	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.44e-05	0.000238	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.42e-05	0.000237	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.41e-05	0.000237	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.4e-05	0.000236	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.4e-05	0.000236	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.4e-05	0.000236	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.39e-05	0.000235	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000235	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.38e-05	0.000234	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.38e-05	0.000234	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.36e-05	0.000233	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.34e-05	0.000231	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.34e-05	0.000231	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.33e-05	0.000231	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000231	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.32e-05	0.00023	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.3e-05	0.000228	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000228	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.27e-05	0.000226	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.24e-05	0.000225	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000224	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.19e-05	0.000221	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.18e-05	0.00022	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.17e-05	0.00022	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.14e-05	0.000218	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.14e-05	0.000217	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.13e-05	0.000217	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000217	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.11e-05	0.000216	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.1e-05	0.000215	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.09e-05	0.000214	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.08e-05	0.000213	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.07e-05	0.000213	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.06e-05	0.000212	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.05e-05	0.000211	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.00021	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.02e-05	0.00021	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.99e-05	0.000207	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.95e-05	0.000204	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.84e-05	0.000197	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.83e-05	0.000196	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.78e-05	0.000193	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.77e-05	0.000192	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.74e-05	0.00019	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.68e-05	0.000186	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.61e-05	0.000181	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.52e-05	0.000175	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.5e-05	0.000173	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.46e-05	0.00017	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.43e-05	0.000168	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.4e-05	0.000166	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.36e-05	0.000163	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.35e-05	0.000163	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.31e-05	0.00016	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.26e-05	0.000157	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.23e-05	0.000154	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.18e-05	0.000151	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000149	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.09e-05	0.000145	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.06e-05	0.000143	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.05e-05	0.000142	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.02e-05	0.00014	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.02e-05	0.00014	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000137	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000135	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.95e-05	0.000135	CbGpPWpGaD
Flupentixol—DDC—Metabolism—EP300—attention deficit hyperactivity disorder	1.92e-05	0.000133	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.92e-05	0.000133	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000132	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.89e-05	0.000131	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.00013	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.86e-05	0.000129	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.85e-05	0.000128	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000128	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.83e-05	0.000127	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.82e-05	0.000126	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000126	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.81e-05	0.000126	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.8e-05	0.000125	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.8e-05	0.000125	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.8e-05	0.000125	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000124	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000124	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.77e-05	0.000123	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000122	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.68e-05	0.000116	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.67e-05	0.000116	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.65e-05	0.000114	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000114	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.00011	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.44e-05	9.99e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.37e-05	9.51e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.19e-05	8.28e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.17e-05	8.1e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.98e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.09e-05	7.57e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.08e-05	7.52e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.38e-06	5.81e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.33e-06	4.39e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.23e-06	4.32e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.19e-06	4.29e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.1e-06	4.23e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.69e-06	3.25e-05	CbGpPWpGaD
